Skip to main content
. 2020 Jul 8;43(9):2017–2024. doi: 10.2337/dc19-2606

Figure 1.

Figure 1

A: The association between mean glucose levels (mmol/L) and time with glucose level <3.9 mmol/L (<70 mg/dL) at baseline, at the end of conventional (SMBG) treatment, and at the end of CGM treatment. B: The association between mean glucose levels (mmol/L) and time with glucose level <3.0 mmol/L (<54 mg/dL) at baseline, at the end of conventional (SMBG) treatment, and at the end of CGM treatment.